Listed

American Vanguard Corp: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 1, 2015 and accepted by EDGAR at May 1, 2015, 12:46 ET.

Share

Management's discussion and analysis

As filed, 24,878 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

FORWARD-LOOKING STATEMENTS/RISK FACTORS:

The Company, from time-to-time, may discuss forward-looking statements including assumptions concerning the Company’s operations, future results and prospects. These forward-looking statements are based on current expectations and are subject to a number of risks, uncertainties and other factors. In connection with the Private Securities Litigation Reform Act of 1995, the Company provides the following cautionary statements identifying important factors which, among other things, could cause the actual results and events to differ materially from those set forth in or implied by the forward-looking statements and related assumptions contained in the entire Report. Such factors include, but are not limited to: product demand and market acceptance risks; the effect of economic conditions; weather conditions; changes in regulatory policy; the impact of competitive products and pricing; changes in foreign exchange rates; product development and commercialization difficulties; capacity and supply constraints or difficulties; availability of capital resources; general business regulations, including taxes and other risks as detailed from time-to-time in the Company’s reports and filings filed with the U.S. Securities and Exchange Commission (the “SEC”). It is not possible to foresee or identify all such factors. For more detailed information, refer to Item 1A., Risk factors and Item 7A., Quantitative and Qualitative Disclosures about Market Risk, in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.

RESULTS OF OPERATIONS

Quarter Ended March 31:

Net sales: 2015 2014 Change
Insecticides $34,359 $46,437 $(12,078)
Herbicides/soil fumigants/fungicides 21,840 22,931 (1,091)
Other, including plant growth regulators 3,322 3,807 (485)
Total crop 59,521 73,175 (13,654)
Non-crop 7,044 7,920 (876)
$66,565 $81,095 $(14,530)
Cost of sales:
Insecticides $22,603 $30,588 $(7,985)
Herbicides/soil fumigants/fungicides 13,590 13,470 120
Other, including plant growth regulators 1,369 3,435 (2,066)
Total crop 37,562 47,493 (9,931)
Non-crop 4,353 4,697 (344)
$41,915 $52,190 $(10,275)
Gross margin:
Insecticides $11,756 $15,849 $(4,093)
Herbicides/soil fumigants/fungicides 8,250 9,461 (1,211)
Other, including plant growth regulators 1,953 372 1,581
Gross margin crop 21,959 25,682 (3,723)
Gross margin non-crop 2,691 3,223 (532)
$24,650 $28,905 $(4,255)
Gross margin crop 37% 35%
Gross margin non-crop 38% 41%
Total gross margin 37% 36%
2015 2014 Change
Net sales:
US $49,222 $57,956 $(8,734)
International 17,343 23,139 (5,796)
$66,565 $81,095 $(14,530)

17

Overall financial performance including net sales and net income for the quarter ended March 31, 2015 was significantly lower as compared to the same period in 2014. Our net sales for the period declined 18% to $66,565, as compared to $81,095 for the first quarter of 2014. Net sales for our crop business are down 19%, and net sales for our non-crop products are down 11%. Our international sales were down by 25% and ended at $17,343. A more detailed discussion of general market conditions and sales performance by category of products appears below.

Our first quarter sales performance was significantly influenced by soft market conditions in the Midwest corn market. For a variety of reasons, large quantities of crop protection products used by corn growers accumulated in the agricultural distribution channel during 2013. These excess carryover inventories prompted a sharp reduction in restocking orders throughout 2014 and into the spring planting season of 2015. While these elevated inventory levels have been reduced, procurement continues to be challenged by continued low corn commodity prices. The prospect of lower profitability has caused some growers to delay or trim their planting season purchases of our corn products as they seek to reduce their overall 2015 corn input costs.

Across our crop business, net sales of our insecticides group were down approximately 26% to end at $34,359, as compared to $46,437 during the first quarter of 2014. Within this segment, net sales of our granular soil insecticides were down approximately 25%, largely for the reasons cited above affecting the U.S. corn market. Our sales of Mocap® and Nemacur® insecticides, which are used primarily outside the U.S. market, were slightly lower than the prior year. Thimet® sales for use in peanuts and sugar cane plantings were somewhat lower in the first quarter of 2015 due to a shift in purchase timing. Net sales of our non-granular insecticides used in crop applications decreased 35% in 2015, as compared to the same period of the prior year. Our cotton foliar insecticide Bidrin® represented approximately one-half of that decline due to reduced cotton acres, with the balance spread across the other products including those that face generic competition (acephate, bifenthrin and permethrin).

Within the group of herbicides/fungicides/fumigants used in crop applications, net sales for the first quarter of 2015 declined by approximately 5% to $21,840 from $22,931 in the comparable period in 2014. Net sales of our herbicide products were down due primarily to higher than normal inventory of corn products in the distribution channel and delayed purchasing this year as growers order cautiously in light of challenging crop commodity prices. As a result, net sales of our post-emergent herbicide Impact® were approximately half of their prior year total. This was partially offset by our sales of Dacthal® which increased by approximately 25% over the prior year due to additional penetration of the onion market. Our soil fumigants business grew by approximately 12% over the prior year’s first quarter with early spring purchases, while our year-over-year PCNB fungicide sales were essentially flat.

Within the group of other products (which includes plant growth regulators, molluscicides and tolling activity), net sales were down approximately 13% as compared to the first quarter of 2014. This performance was driven by solid gains in our plant growth regulator NAA and our Metaldehyde granules, offset by a reduction in toll manufacturing revenue during the first quarter.

Our non-crop sales ended the first quarter of 2015 at $7,044 as compared to $7,920 for the same period of the prior year. This decrease was primarily driven by sales of our aerial mosquito adulticide Dibrom®, which were down approximately 25% as a result of channel inventory after a light hurricane season in the Gulf Coast region during 2014.

Our international sales ended at $17,343 as compared to $23,139 for the first quarter of the prior year, primarily related to the loss of an annual bid on banana plantations in Costa Rica. Additionally, part of the reduction in sales related to sales denominated in Euros, which were impacted by the reduction in the Euro/Dollar exchange rate.

Our cost of sales for the first quarter of 2015 was $41,915 or 63% of net sales. This compared to $52,190 or 64% of net sales for 2014. The Company aggregates a number of key variable, semi-variable and fixed cost components within reported cost of sales. The two major cost components are raw materials (including sub contract costs) and factory operating costs. During the quarter, our raw material costs decreased by 18%, consistent with the reduction in sales. Our factory expenses were down by approximately 23% year-over-year as we focused on managing our factory costs during this period of low output. As a result, our gross margin ended at 37% of sales, as compared to 36% in the same period of the prior year.

Operating expenses decreased by $599 to $24,344 for the three months ended March 31, 2015 as compared to the same period in 2014. The differences in operating expenses by department are as follows:

2015 2014 Change
Selling $7,375 $8,171 $(796)
General and administrative 6,340 6,474 (134)
Research, product development and regulatory 4,837 4,733 104
Freight, delivery and warehousing 5,792 5,565 227
$24,344 $24,943 $(599)
  • Selling expenses decreased by $796 to end at $7,375 for the three months ended March 31, 2015, as compared to the same period of 2014. The main drivers are a decrease in advertising expenses and other sales and marketing support services.
  • General and administrative expenses were comparatively flat and ended at $6,340 for the three months ended March 31, 2015, as compared to the same period of 2014.
  • Research, product development costs and regulatory expenses were comparatively flat and ended at $4,837 for the three months ended March 31, 2015, as compared to the same period of 2014.
  • Freight, delivery and warehousing costs for the three months ended March 31, 2015 were $5,792 or 8.7% of sales as compared to $5,565 or 6.9% of sales for the same period in 2014. This is due to higher average inventory levels driving increased warehouse costs, the mix of sales, including an increase in high volume bulk fumigant products, in comparison to the same period of the prior year.

Interest costs net of capitalized interest, were $641 in the first three months of 2015 as compared to $613 in the same period of 2014. Interest costs are summarized in the following table:

Average Indebtedness and Interest expense

Q1 2015 Average Debt Interest Expense Interest Rate Q1 2014 Average Debt Interest Expense Interest Rate
Revolving line of credit 106,449 516 2.0% 75,477 489 2.6%
Average $106,449 $516 2.0% $75,477 $489 2.6%
Notes payable 191 1 — 186 2 —
Amortization of deferred loan fees — 106 — — 59 —
Amortization of other deferred liabilities — 47 — — 69 —
Other interest expense — 10 — — 12 —
Capitalized Interest — (39) — — (18) —
Total $106,640 $641 2.4% $75,663 $613 3.2%

The Company’s average overall debt for the three months ended March 31, 2015 was $106,640, as compared to $75,663 for the three months ended March 31, 2014. During the quarter, we increased our usage of revolving debt to fund elevated levels of working capital due primarily to the timing of collections on outstanding receivables. As can be seen from the table above, our effective bank interest rate was 2.0% for the three months ended March 31, 2015 as compared to 2.6% in 2014. This rate improvement is driven by the decision not to replace the interest rate swap contract which expired on December 31, 2014.

Income tax expense decreased by $1,308 to end at a benefit of $292 for the three months ended March 31, 2015 as compared to an expense of $1,016 for the comparable period in 2014. The effective tax rate for the quarter was 87.2% (which was a tax benefit) as compared to 30.0% (which was a tax expense) in the same period of the prior year. The change in effective tax rate is primarily due to comparatively higher earnings in our international tax jurisdictions that are taxed at a comparatively lower rate than the U.S. statutory rates and projected loss in the U.S.

The effective tax rate for the three months ended March 31, 2015 is based on the projected income for the full year and is subject to ongoing review and adjustment by management.

During the three months ended March 31, 2015 we did not recognize a gain or loss on our investment in TyraTech, as compared to recognizing a loss of $328 during the three months ended March 31, 2014. The loss recorded during the three months ended March 31, 2014 is inclusive of a gain of $256 related to the sale by TyraTech of additional stock.

Non-controlling interest for the three months ended March 31, 2015 improved to $94 as compared to $154 for the three months ended March 31, 2014. Non-controlling interest represents the share of net loss that is attributable to TyraTech’s share, the minority stockholder, of our majority owned subsidiary, Envance.

Our overall net income for the first three months of 2015 was $51 or $0.00 per basic and diluted share, as compared to $2,159 or $0.07 per diluted share ($0.08 per share – basic) in the same quarter of 2014.

LIQUIDITY AND CAPITAL RESOURCES

Net cash generated by operating activities during the three months ended March 31, 2015 amounted to $19,842, as opposed to utilizing $41,890 in the same period of the prior year. Net loss of $43, non-cash depreciation, amortization of intangibles, other assets and discounted future liabilities generated $5,433, as compared to $5,256 in the prior year. Additionally, stock based compensation of $1,427 and changes in other assets and liabilities provided net cash inflow of $6,816, as compared to $7,866 being utilized in the same period of 2014.

During the three months ended March 31, 2015, net sales were down by approximately 18%. In comparison to the same period of the prior year, accounts receivables are down 20% ending at $82,028. The minor difference between the percentage reduction in net sales and in accounts receivable is primarily driven by variations in terms associated with different products and markets.

Inventories ended at $166,981, which was broadly in line with the level of $165,631 at December 31, 2014. We believe that in-channel inventories are continuing to reduce and should allow more normal levels of buying to occur as we progress through 2015 and into the 2016 growing season. It should also be noted that the Company purchases and holds raw material, intermediate or finished goods inventory from time to time based on a single annual purchase from a single source or supplier, potentially resulting in peaks in the carrying value of inventory. Furthermore, in order to achieve efficient manufacturing runs, the Company may manufacture a particular product only one time a year and then carry high levels of that inventory for a period. As of the balance sheet date, March 31, 2015, we believe our inventories are valued at lower of cost or market.

Our deferred revenues increased as some customers decided to pay in advance for product deliveries later in the growing season.

The Company accrues programs in line with the growing season upon which specific products are targeted. Typically crop products have a growing season that ends on September 30th each year. During the three months ended March 31, 2015, the Company made accruals in the amount of $12,670. Programs are primarily paid out to customers either in the final quarter of the fiscal year or the first quarter of the next fiscal year. During the first three months of 2015, the Company made payments in the amount of $7,220. Payments are not generally significant in the second and third quarters of each fiscal year. During the three months ended March 31, 2014, the Company accrued $16,264 and made payments in the amount of $7,938.

Our prepaid and other assets increased by $1,301 as we made a prepayment of $1,500 in connection with the acquisition of the Nemacur product line in the E.U.; as reported above, that transaction closed on April 2, 2015. Furthermore, accounts payable and accrued expenses increased by $8,784 as compared to an increase of $4,669 during the same period of 2014 as timing of payments are made for inventory purchases.

The Company utilized $1,522 from investing activities during the three months ended March 31, 2015, compared to utilizing $1,816 during the same period of 2014. This is primarily driven by decisions to make short term reductions in capital spending in our factories.

Financing activities utilized $16,084 by paying down on the line of credit during the three months ended March 31, 2015, as opposed to providing $45,398 from borrowings on the line of credit in the same period of the prior year. This included a net repayment of $14,400 against our senior credit facility. During the quarter, the Company utilized $351 to make scheduled deferred payments related to product acquisitions. Further, the Company made dividend payments in the amount of $569 and received $200 as a short-term note at one of our subsidiaries. Finally, the Company utilized $1,244 upon vesting of shares and exercise of stock options and received $280 from the sale of common stock under its Employee Stock Purchase Plan (including associated tax benefits of $1) as compared to $1,253 for the same period of last year.

The Company has a revolving line of credit and various notes payable that together constitute the short-term and long-term loan balances shown in the condensed consolidated balance sheets at March 31, 2015 and December 31, 2014. These are summarized in the following table:

Indebtedness $000’s March 31, 2015 Long- term Short- term Total December 31, 2014 Long- term Short- term Total
Revolving line of credit $85,000 $— $85,000 $99,400 $— $99,400
Notes payable 36 272 308 55 71 126
Total indebtedness $85,036 $272 $85,308 $99,455 $71 $99,526

The Company has three key covenants to its senior, secured credit facility with its banking syndicate. The covenants are as follows: (1) the Company must maintain its borrowings below a certain consolidated funded debt ratio (taking into account the Company’s twelve month trailing EBITDA), (2) the Company has a limitation on its annual spending on the acquisition of fixed asset capital additions, and (3) the Company must maintain a certain consolidated fixed charge coverage ratio. As of March 31, 2015 the Company met all covenants in that credit facility.

At March 31, 2015, based on its performance against the most restrictive covenants listed above, the Company had the capacity to increase its borrowings by up to $22,710 under the credit facility agreement. This compares to an available borrowing capacity of $87,814 as of March 31, 2014. This decrease in borrowing availability arises from reduced financial performance (as measured in EBITDA) for the trailing twelve month period.

We believe that anticipated cash flow from operations, existing cash balances and available borrowings under our senior credit facility will be sufficient to provide us with liquidity necessary to fund our working capital and cash requirements for the next twelve months.

RECENTLY ISSUED ACCOUNTING GUIDANCE

In April 2015, The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-03, Interest – Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. This ASU requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments in this update. ASU 2015-03 is effective for financials statement issued for fiscal years beginning after December 15, 2015. The Company is evaluating the impact of this update and will adopt this update.

In August 2014, FASB issued ASU2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. This ASU requires that management of an entity assesses whether there is substantial doubt about the ability of the entity to continue as a going concern and for making the appropriate disclosures. The assessment must be performed at each annual and interim reporting period, and there is substantial doubt about an entity’s ability to continue as a going concern if it is probable that the entity will be unable to meet its obligations as they become due within 12 months of the date of the financial statements are issued. In the assessment, management must consider the information available at the date of issuance of the financial statements, as well as mitigating factors and plans to alleviate the substantial doubt. ASU 2014-15 is effective for annual period ending after December 15, 2016 and interim periods thereafter. Early application is permitted. Upon adoption, the Company will follow the guidance in this ASU when assessing going concern.

In June 2014, FASB issued ASU 2014-12, Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, a consensus of the FASB Emerging Issues Task Force. ASU 2014-12 requires that a performance target that affects vesting of share-based payment awards and that could be achieved after the requisite service period be treated as a performance condition. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the periods for which the requisite service has already been rendered. If the performance target becomes probable of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized prospectively over the remaining requisite service period. The total amount of compensation cost recognized during and after the requisite service period should reflect the number of awards that are expected to vest and should be adjusted to reflect those awards that ultimately vest. The requisite service period ends when the employee can cease rendering service and still be eligible to vest in the award if the performance target is achieved. ASU 2014-12 is effective for all entities for interim and annual periods beginning after December 15, 2015, with early adoption permitted. An entity may apply the amendments in ASU 2014-12 either (i) prospectively to all awards granted or modified after the effective date or (ii) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. The adoption of ASU 2014-12 is not expected to have a material impact on the Company’s consolidated financial condition or results of operations.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers. ASU 2014-09 outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard in 2017 or its impact on our consolidated financial statements.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The Company continually re-assesses the critical accounting policies used in preparing its financial statements for inclusion in the American Vanguard published financial statements. In the Company’s consolidated Form 10-K for the financial year ended December 31, 2014, the Company provided a comprehensive statement of critical accounting policies. These policies have been reviewed in detail as part of the preparation work for this Form 10-Q. After our review of these matters, we have determined that, during the subject reporting period, there has been no material change to the critical accounting policies that are listed in the Company’s Form 10-K for the year ended December 31, 2014.

Market risk

As filed, 1,409 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company is exposed to market risk related to changes in interest rates, primarily from its borrowing activities. The Company’s indebtedness to its primary lender is evidenced by a line of credit with a variable rate of interest, which fluctuates with changes in the lender’s reference rate. For more information, please refer to the applicable disclosures in the Company’s Form 10-K filed with the SEC for the year ended December 31, 2014. The Company used derivative financial instruments for trading purposes to protect trading performance from exchange rate fluctuations on material contracts.

The Company conducts business in various foreign currencies, primarily in Europe, Mexico, Central and South America. Therefore changes in the value of the currencies of such countries or regions affect the Company’s financial position and cash flows when translated into U.S. Dollars. The Company has mitigated and will continue to mitigate a portion of its currency exchange exposure through natural hedges based on the operation of decentralized foreign operating companies in which the majority of all costs are local-currency based. Furthermore, the Company has established a procedure for covering forward exchange rates on specific purchase orders when appropriate. A 10% change in the value of all foreign currencies would have an immaterial effect on the Company’s financial position and cash flows.

Controls and procedures

As filed, 1,070 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of March 31, 2015, the Company has established a comprehensive set of disclosure controls and procedures designed to ensure that all information required to be disclosed in our filings under the Securities Exchange Act (1934) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. As of March 31, 2015, the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer have concluded, based on their evaluation, that the Company’s disclosure controls and procedures are effective to provide reasonable assurance of the achievement of the objectives described above.

There were no changes in the Company’s internal controls over financial reporting that occurred during the most recent quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

PART II. OTHER INFORMATION

The Company was not required to report any matters or changes for any items of Part II except as disclosed below.

Risk factors

As filed, 410 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company continually re-assesses the business risks, and as part of that process detailed a range of risk factors in the disclosures in American Vanguard’s Report on Form 10-K for the fiscal year ended December 31, 2014, filed on February 27, 2015. In preparing this document, we have reviewed all the risk factors included in that document and find that there are no material changes to those risk factors.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$66.6mus-gaap:SalesRevenueNet
Cost of revenue3 months2015-01-01 to 2015-03-31$41.9mus-gaap:CostOfRevenue
Gross profit3 months2015-01-01 to 2015-03-31$24.6mus-gaap:GrossProfit
Operating income3 months2015-01-01 to 2015-03-31$306.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2015-01-01 to 2015-03-31$680.0kus-gaap:InterestExpense
Income tax3 months2015-01-01 to 2015-03-31−$292.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-01-01 to 2015-03-31$51.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2015-01-01 to 2015-03-31$0.00us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-01-01 to 2015-03-31$0.00us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-01-01 to 2015-03-3128,839,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2015-01-01 to 2015-03-31$19.8mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Dividends paid3 months2015-01-01 to 2015-03-31$569.0kus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2015-03-31$6.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$288.3mus-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$470.7mus-gaap:Assets
Current liabilitiesAt period end2015-03-31$93.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-03-31$210.1mus-gaap:Liabilities
Long-term debtAt period end2015-03-31$85.0mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2015-03-31$272.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2015-03-31$261.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-15-165500. Last ingested by Listed: Nov 11, 2026, 00:16 ET. Listed shows no prices and gives no investment advice.